公司簡介
Actavis is a leading pharmaceutical group ranked first 50 in worldwide pharmaceutical industry, and 3rd in global generic field with the headquarter located in Jersey, USA. Actavis develops its business in over 60 countries or regions, selling more than 1000 kinds of products. Actavis also has over 600 kinds of products being developed or registered at present. All the products cover in central nervous system, alimentary tract, cardiovascular system, metabolism, anti-infectives, respiratory system, etc.
公司發展
Actavis (Foshan) is the production, sales & marketing and R&D base in China for Actavis Group. The earliest predecessor of Actavis (Foshan) is the Foshan pharmaceutical plant, which was founded in 1958, and acquired by FH Faulding from Australia in 1994, then by Alpharma from USA in 2001. Actavis (Foshan) became part of Actavis group in late 2005 with the formal name of Actavis (Foshan) Pharmaceutical Co., Ltd.
阿特維斯集團是一間總部位於美國新澤西州的製藥公司，位居全球醫藥企業50強，全球通用名藥企業第3強，其業務遍及全球60多個國家或地區。目前在產和銷售的產品1000多種，研發中和註冊中的產品600多種，涉及中樞神經、消化、心血管、代謝、抗感染、呼吸等多個領域。
阿特維斯（佛山）製藥有限公司是阿特維斯集團在中國的研發、生產和銷售基地，其前身是成立於1960年的佛山製藥廠，後來歷經澳洲康寶順（佛山）製藥有限公司、美國雅來（佛山）製藥有限公司，在2005年底發展成為現在的阿特維斯（佛山）製藥有限公司。
阿特維斯堅持在研發，生產與服務都執行最高標準。我們歡迎與全國經銷商一起為顧客提供“歐盟品質、中國價格”的好藥。中國大陸區業務作為阿特維斯全集團發展戰略重要的一環，其光明的前景勢必為全集團成為更優秀的通用名藥企業做出巨大貢獻。
